![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Shanghai Osd Co., Ltd. Shanghai Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Allopurinol, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R0-CEP 2004-189 - Rev 02
This Chemical Type CEP, issued on September 26, 2008, remains in force until October 04, 2010, ensuring its reliability within the pharmaceutical industry.
Substance Number 576 associated with this CEP further emphasizes